FBXO32 and neoplasm: FBXO32 is assumed as a functional tumor suppressor, and FBXO32 gene reactivation may have a therapeutic potential, indicating its role as a prognostic marker for CGA cases.85 It is demonstrated that the loss of RKIP expression and hypermethylation can be regarded as a marker to anticipate clinical result of CGA.